DOI QR코드

DOI QR Code

Early Diagnosis Behavior in Turkish Women with and without a Family History of Cervical Cancer

  • Gunaydin, Cansu (Istanbul University, Istanbul Faculty of Medicine, Department of Urogynecology) ;
  • Gencturk, Nuran (Istanbul University Faculty of Health Sciences/Midwifery)
  • Published : 2015.02.25

Abstract

Background: This study was planned as comparative and descriptive in order to measure and evaluate the knowledge and attitudes regarding early diagnosis of women with and without a family history of cervical cancer. Materials and Methods: The study sample consisted of the relatives of female patients (N=253) who were admitted to Istanbul University of Medicine. Women with a family history of cervical cancer formed the case group, while those without family history of cervical cancer constituted the control group. Two distinct data collection tools, a questionnaire and the Miller Behavioral Style Scale (MBSS), were used in order to obtain data for evaluation with SPSS for Windows 20.0 statistics package program. Results: It was found that 61.0% of the case group with family history of cervical cancer and 19.0% of the control group without family history of cervical cancer were using early diagnostic methods. Thus the presence of an individual with cervical cancer in the family affected the attitudes towards early diagnosis. It was further found that the level of knowledge on cervical cancer and PAP smear test was higher in the case group, which was more sensitive with regard to being informed about cervical cancer as compared to general society. However, the average MBSS scores were not significantly different compared to the control group. Conclusions: It was noted that, women participating this study knowledgeable, but this did not necessarily transform into better behavior.

Keywords

References

  1. Acikgoz A, Cehreli R, Ellidokuz H (2011). Women's knowledge and attitudes about cancer and early detection methods for their behavior. Dokuz Eylul Univ Fac Medicine Magazine, 25, 145-54.
  2. Akyuz A, Guvenc G, Yavan T, Cetinturk A, Kok G (2006). Situation of women with Pap Tests determination of factors influencing. Gulhane Medical Journal, 48, 25-9.
  3. Anttila A, Ronco G, Clifford G, et al (2004). Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer, 91, 935-41.
  4. Ayhan A, Basaran M (2006). Invasive cervical cancers. In MS Beksac, N Demir, ZS Tuncer, et al (Eds.). Gynecology, Reproductive Endocrinology and Infertility and Gynecologic Oncology, (pp.1364-1367). Ankara: Medical Network.
  5. Bekar M (2008). Benign and malignant tumors of the female genital tract. In A Sirin, O Kavlak (Eds.). Women's Health (1st ed., pp. 422-429). Istanbul: Kenan Offset Printing.
  6. Bilge A, Unal G (2005). Anger and anxiety levels in patients with cancer of the determination. Ege University School of Nursing Journal, 21, 37-46.
  7. Brabin L, Roberts SA, Farzaneh F, Kitchener HC (2006). Future acceptance of adolescent human papillomavirus vaccination: A survey of parental attitudes. Br J Cancer, 24, 3087-94.
  8. Dinh TA, Rosenthal SL, Doan ED, et al (2007). Attidues of mothers in Da Nang, Vietnam toward a human papillomavirus vaccine. J Adolescent Health, 40, 559-63. https://doi.org/10.1016/j.jadohealth.2007.02.003
  9. Dozier KJ, Lawrence D (2000). Socio-demographicpredictors of adherence to annual cervical cancer screening in minority women. Cancer Nursing, 23, 350-6. https://doi.org/10.1097/00002820-200010000-00004
  10. Ertem G (2009). Awareness of cervical cancer risk factors and screening behaviour among nurses in a rural region of Turkey. Asian Pac J Cancer Prev, 10, 735-8.
  11. Giles M, Garland S (2006). A study of women's knowledge regarding human papilloma virus infection, cervical cancer and human papilloma virus vaccines, Aust NZ J Obstets Gynaecol, 46, 311-5. https://doi.org/10.1111/j.1479-828X.2006.00598.x
  12. Gokaslan H and Uyar EE (2004). Cervical cancer screening with the pap smear. Turkish J Family Practice, 8, 105-10.
  13. Gumus AB and Cam O (2011). Relationships between early diagnosis attitudes in cervical cancer of women and levels of self-esteem, body perception and hopelessness. Medicus Nobel, 7, 46-52.
  14. Hacimustafaoglu M (2011). Routine immunisation schedules of Turkey; extended immunisation schedule. J Pediatric Infectious, 5, 244-51.
  15. International Agency for Research on Cancer (2012). Cervical cancer estimated incidence mortality and prevalence worldwide in 2012 at: http://globocan.iarc.fr/old/FactSheets/cancers/cervix-new.asp
  16. Isik Andsoy I, Gul A (2014). Breast, cervix and colorectal cancer knowledge among nurses in Turkey. Asian Pac J Cancer Prev, 15, 2267-72. https://doi.org/10.7314/APJCP.2014.15.5.2267
  17. Kose MF (2006). Cervical intraepithelial diseases. In N. Cicek, C. Akyurek, C Celik, A Haberal (Eds.). Obstetrics and Accurate Information (pp. 98, 1153-1446). Istanbul: Gunes Bookshop Ltd.Std.
  18. Lenehan JG, Leonard KC, Nandra S, et al (2008). Women's knowledge, attitudes and intentions concerning human papillomavirus vaccination: findings of a waiting room survey of obstetrics-gynaecology outpatients. J Obsts Gynaecol Can, 30, 489-99. https://doi.org/10.1016/S1701-2163(16)32864-X
  19. Moraros J, Bird Y, Barney DD, et al (2006). A pilot study: HPV infection knowledge and HPV vaccine acceptance among women residing in ciudad juarez, Mexico. Californian J Health Promotion, 4, 177-86.
  20. Numanoglu C (2010). Preinvasive lesions of the lower genital tract. In Ceylan Y, Yildirim G, Aslan, H, Gul A, Gedikbasi A (Eds.), Williams Gynecology (pp. 29, 622-625). Istanbul: Medical Nobel Bookstores.
  21. Ozan H (2005). PAP Smear: When? How? Who? Turkey J Gynecol Obstetrics, 2, 35-40.
  22. Ozan YD and Ertem M (2011). In Diyarbakir, the frequency of cervical cancer screening in different occupational groups and knowledge; 2007. Turkish J Family Practice, 15, 147-52.
  23. Ozdemir O, Bilgili N (2010). Knowledge and practices of nurses working in an education hospital on early diagnosis of breast and cervix cancers. Prev Medicine Bull, 9, 605-12.
  24. Saraiya UB (2003). Preventable but not prevented: the reality of cervical cancer. JObstetrican Gynecology, 29, 351-9.
  25. Saslow D, Runowicz CD, Solomon D (2002). American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA A Cancer J Clin, 52, 342-62. https://doi.org/10.3322/canjclin.52.6.342
  26. Sirovich BE and Welch HG (2004). Cervical cancer screening among women without a cervix. J Am Med Assoc, 291, 2990-3. https://doi.org/10.1001/jama.291.24.2990
  27. Waxman AG (2005). Guidelines for cervical cancer screening, history and scientific rationale. Clin Obstet Gynecol, 48, 77-97. https://doi.org/10.1097/01.grf.0000151590.08451.26
  28. World Health Organization. (2008). Globocan 2008, Fast Stats, Less Developed Regions; Men, Women, Both Sexes, Summary Statistics (Access Date: 01.03.2012). http://globocan.iarc.fr/factsheets/populations/factsheet.asp?uno=902#WOMEN
  29. Yildirim JG and Arabaci Z (2014). Innovations in HPV vaccination and roles of nurses in cervical cancer prevention. Asian Pac J Cancer Prev, 15, 10053-6.

Cited by

  1. Factors affecting Pap smear uptake in a maternity hospital: A descriptive cross-sectional study vol.74, pp.11, 2018, https://doi.org/10.1111/jan.13769